| __timestamp | Bausch Health Companies Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 4326000 |
| Thursday, January 1, 2015 | 2682700000 | 226206000 |
| Friday, January 1, 2016 | 2810000000 | 94391000 |
| Sunday, January 1, 2017 | 2582000000 | 53821000 |
| Monday, January 1, 2018 | 2473000000 | 35463000 |
| Tuesday, January 1, 2019 | 2554000000 | 46456000 |
| Wednesday, January 1, 2020 | 2367000000 | 71318000 |
| Friday, January 1, 2021 | 2624000000 | 135256000 |
| Saturday, January 1, 2022 | 2625000000 | 102708000 |
| Sunday, January 1, 2023 | 2917000000 | 129620000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. Bausch Health Companies Inc. and ImmunityBio, Inc. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Bausch Health, a giant in the sector, consistently reported SG&A expenses that were over 20 times higher than those of ImmunityBio, reflecting its expansive operations and market reach. Notably, Bausch Health's expenses peaked in 2023, showing a 44% increase from 2014. In contrast, ImmunityBio, a smaller player, demonstrated a more volatile pattern, with a significant spike in 2015, where expenses surged by over 5000% compared to the previous year. This divergence highlights the varied financial strategies and operational scales of these companies, offering insights into their market positioning and growth trajectories.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing BeiGene, Ltd. and Bausch Health Companies Inc.
Insmed Incorporated or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Ascendis Pharma A/S or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Grifols, S.A. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: ImmunityBio, Inc. vs Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.